Insulin can inhibit the breakdown of fat in adipose tissue under catecholamine stimulation and stimulate the uptake of glucose in adipocytes for storage as fat, thereby promoting lipogenesis, leading to increased VLDL and reduced HDL particle production, manifesting as elevated plasma triglycerides, decreased HDL cholesterol, and abdominal obesity (40–42). Here, INS is linked to Abdominal obesity.